Interestingly, the expression patterns of DCAF4, COX10, and TGOLN2 presented the best tool set to identify and separate cell lines with their respective irinotecan-resistant variants from other pairs of parental–resistant CRC cells lines that were delivered from different cancer locations or stages. This evidence concerns the gene TGOLN2 and colorectal carcinoma.